Filing Flows › Cirtran (CIRX) › Q1 2025
Cirtran (CIRX) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 20, 2025
Cirtran (CIRX) reported revenue of $461K for the first quarter 2025 (Q1 2025), +7% from a year earlier and +109% from the quarter before. Operating margin was -9.4%, net loss $155K (33.7% of revenue).
Cirtran, Q1 2025: revenue $461K (+7% year over year), operating margin -9.4%, net loss $155K, operating cash flow −$468K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $461K | +109% | +7% |
| Operating profit | −$43K | — | — |
| Net earnings | −$155K | — | — |
| Operating cash flow | −$468K | — | — |
What changed
Revenue was $461K in Q1 2025, up 7% year over year and up 109% from the previous quarter. Tobacco Line was the largest line at 93% of revenue.
Gross margin was 58.7%, down 4.6 points from a year earlier. Operating costs exceeded revenue by $43K, an operating margin of -9.4%. Operating expenses fell 1% while revenue rose 7%. The quarter ended with a net loss of $155K, narrower than the previous quarter's $813K loss. Net interest and other expense of $103K was the main reason.
Operating cash flow was −$468K. Non-cash charges added back $1K of depreciation. Working capital and other items used $313K.
Questions
What was Cirtran's revenue in the first quarter 2025?
Cirtran (CIRX) reported revenue of $461K for the first quarter 2025 (Q1 2025), +7% from a year earlier and +109% from the quarter before.
Was Cirtran profitable in the first quarter 2025?
Operating loss was $43K (-9.4% of revenue) and net loss $155K.
Source: Cirtran 10-Q on SEC EDGAR.